We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close
Focus On
NEW In-House Counsel | Insurance | Intellectual Property | Immigration | Natural Resources | Real Estate | Tax

Health Law - Public health - Food and drug safety - Practice and procedure - General principles - Legislation - Interpretation - Statutes

Thursday, September 22, 2016 @ 8:00 PM  

Appeal by defendant from convictions for numerous offences under the Food and Drugs Act (FDA). Between 2008 and 2010, the appellant marketed and sold a variety of products containing 1-Benzyl-Piperazine (BZP), a substance similar to an amphetamine. During that time, BZP was not listed under any schedule in the FDA or the Controlled Drugs and Substances Act. Health Canada repeatedly warned the appellant that it considered BZP to be a drug and requested that he apply for the necessary licenses and approvals. Eventually, the appellant and...